These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1490701)

  • 21. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
    Al-Mondhiry H; Pierce WS; Pennock JL
    J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral occlusive arterial disease in diabetic clinic attendees.
    Vigilance JE; Reid HL; Richards-George P
    West Indian Med J; 1999 Sep; 48(3):143-6. PubMed ID: 10555462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age.
    Yamanishi J; Sano H; Saito K; Furuta Y; Fukuzaki H
    Thromb Haemost; 1985 Aug; 54(2):539-43. PubMed ID: 2417354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests.
    Gresele P; Catalano M; Giammarresi C; Volpato R; Termini R; Ciabattoni G; Nenci GG; Davì G
    Thromb Haemost; 1997 Dec; 78(6):1434-7. PubMed ID: 9423790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [24-hour arterial pressure study and diabetic neuropathy and angiopathy of the lower limbs].
    Ribeiro C; Geraldes E; Rodrigues D; Barros L; Ruas L; Gomes L; Maldonado J; Pego M; Ruas MC
    Acta Med Port; 1997 Jan; 10(1):33-8. PubMed ID: 9245174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
    Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
    Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-thromboglobulin and platelet aggregates in glomerulonephritis.
    Woo KT; Junor BJ; Salem H; d'Apice AJ; Whitworth JA; Kincaid-Smith P
    Clin Nephrol; 1980 Aug; 14(2):92-5. PubMed ID: 6157505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PARD: platelet aggregation as a risk factor in diabetics: results of a prospective study.
    Breddin HK; Krzywanek HJ; Althoff P; Schöffling K; Uberla K
    Horm Metab Res Suppl; 1985; 15():63-8. PubMed ID: 2934312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Increased pre- and postoperative thrombocyte activity in vascular surgery patients].
    Reininger CB; Reininger AJ; Steckmeier B; Lasser R; Schweiberer L
    Vasa; 1994; 23(3):217-27. PubMed ID: 7975867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet aggregation in obese and diabetic subjects: association with leptin level.
    Sugiyama C; Ishizawa M; Kajita K; Morita H; Uno Y; Matsubara K; Matsumoto M; Ikeda T; Ishizuka T
    Platelets; 2007 Mar; 18(2):128-34. PubMed ID: 17365861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
    Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
    Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
    Fuller JH
    Ann Clin Res; 1984; 16(3):137-41. PubMed ID: 6236737
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet aggregation and plasma levels of beta-thromboglobulin in diabetes mellitus.
    Yamada K; Mori K; Goto Y
    Tohoku J Exp Med; 1981 Dec; 135(4):423-9. PubMed ID: 6175049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.
    Lange S; Diehm C; Darius H; Haberl R; Allenberg JR; Pittrow D; Schuster A; von Stritzky B; Tepohl G; Trampisch HJ
    Exp Clin Endocrinol Diabetes; 2004 Nov; 112(10):566-73. PubMed ID: 15578331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemostasiological parameters as risk factor for new arterial occlusions in diabetics.
    Breddin HK; Krzywanek HJ; Althoff P; Kirchmaier CM; Rosak C; Schepping M; Weichert W; Ziemen M; Schöffling K; Uberla K
    Klin Wochenschr; 1986 Oct; 64(20):1042-6. PubMed ID: 3491249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the relationship of plasma fibrinogen, platelet aggregation rate and peripheral arterial occlusive disease].
    Wang J; Li XY; He Y; Ni B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jan; 26(1):1-4. PubMed ID: 15921581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematologic changes in type 2 diabetic patients with various localizations of peripheral vascular disease.
    Tkác I; Tkácová R; Takác M; Lazúr J
    Vasa; 1992; 21(4):360-4. PubMed ID: 1485469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress is present in atherosclerotic peripheral arterial disease and further increased by diabetes mellitus.
    Belch JJ; Mackay IR; Hill A; Jennings P; McCollum P
    Int Angiol; 1995 Dec; 14(4):385-8. PubMed ID: 8708432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiology of peripheral vascular disease in diabetics (author's transl)].
    Janka HU; Standl E; Oberparleiter F; Bloss G; Mehnert H
    Med Klin; 1979 Feb; 74(8):272-8. PubMed ID: 763220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.